Kemper Corporation announced that its Board of Directors has elected Dr. Suzet M. McKinney as a Director, effective February 7, 2024. The Board announced that Christopher B. Sarofim has informed the Board of his intention to retire as a director at the end of his current term, expiring May 1, 2024. As Principal and Director of Life Sciences for Sterling Bay, the national real estate investment and development firm, McKinney oversees relationships with the scientific, academic, corporate, tech, and governmental sectors involved in the life sciences ecosystem.

She also leads the strategy to expand Sterling Bay?s footprint in life sciences nationwide. Prior to Sterling Bay, she held a number of senior leadership roles in public health and policy administration. McKinney also serves on numerous boards and advisory committees, including the Board of Directors for Wintrust Financial Corporation.

McKinney holds a Doctorate from the University of Illinois at Chicago School of Public Health, a Master of Public Health with certificates in Managed Care and Health Care Administration from Benedictine University, and a Bachelor of Arts in Biology from Brandeis University. Sarofim was elected to Kemper?s Board in May 2013, and has served on the Board?s Investment Committee. He currently serves as Chairman of Fayez, Sarofim & Co., a leader in the financial services and investment management industry.

His community and charitable commitments include serving on the Board of Trustees for The Brown Foundation and Baylor College of Medicine, a member of the Advisory Committee for MD Anderson Cancer Center, and as the Chairman of the Board of Trustees of the Sarofim Foundation.